Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling
- PMID: 26621847
- PMCID: PMC4739685
- DOI: V体育安卓版 - 10.1074/mcp.O115.054940
"V体育2025版" Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling
V体育安卓版 - Abstract
A major goal in cell signaling research is the quantification of phosphorylation pharmacodynamics following perturbations VSports手机版. Traditional methods of studying cellular phospho-signaling measure one analyte at a time with poor standardization, rendering them inadequate for interrogating network biology and contributing to the irreproducibility of preclinical research. In this study, we test the feasibility of circumventing these issues by coupling immobilized metal affinity chromatography (IMAC)-based enrichment of phosphopeptides with targeted, multiple reaction monitoring (MRM) mass spectrometry to achieve precise, specific, standardized, multiplex quantification of phospho-signaling responses. A multiplex immobilized metal affinity chromatography- multiple reaction monitoring assay targeting phospho-analytes responsive to DNA damage was configured, analytically characterized, and deployed to generate phospho-pharmacodynamic curves from primary and immortalized human cells experiencing genotoxic stress. The multiplexed assays demonstrated linear ranges of ≥3 orders of magnitude, median lower limit of quantification of 0. 64 fmol on column, median intra-assay variability of 9. 3%, median inter-assay variability of 12. 7%, and median total CV of 16. 0%. The multiplex immobilized metal affinity chromatography- multiple reaction monitoring assay enabled robust quantification of 107 DNA damage-responsive phosphosites from human cells following DNA damage. The assays have been made publicly available as a resource to the community. The approach is generally applicable, enabling wide interrogation of signaling networks. .
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc V体育安卓版. .
Figures
References
-
- Begley C. G., Ellis L. M., Drug development: Raise standards for preclinical cancer research. Nature. 483, 531–533 - PubMed
-
- Prinz F., Schlange T., and Asadullah K. (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat. Rev. Drug Discov. 10, 712. - VSports注册入口 - PubMed
-
- Tate J., and Ward G. (2004) Interferences in Immunoassay. Clin. Biochem. Rev. 25, 105–120 - VSports在线直播 - PMC - PubMed
-
- Hoofnagle A. N., and Wener M. H. (2009) The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Methods 347, 3–11 - "VSports手机版" PMC - PubMed
Publication types
- VSports在线直播 - Actions
MeSH terms
- "V体育平台登录" Actions
- "VSports手机版" Actions
- V体育平台登录 - Actions
- V体育安卓版 - Actions
- "VSports在线直播" Actions
Substances
- V体育官网入口 - Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
